RxDoctor Payments Data

Khrystyna Cox, NP

Gerontology · Philadelphia, PANPI 1497224042

Payments from drug & device makers

$364in general payments, 2019–2025

Across 14 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$180
  • Tandem Diabetes Care, Inc.$49
  • Insulet Corporation$36
  • Lilly USA, LLC$29
  • Dexcom, Inc.$27
  • RGH Enterprises LLC$16
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$364100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$364 in reported general payments places this provider in the 55th percentile of 383 gerontology providers in Pennsylvania.

See all gerontology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$44,374
Medicare patients
220
Services billed
610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide284$465,118
TrulicityDulaglutide156$246,169
MounjaroTirzepatide149$228,042
JardianceEmpagliflozin99$143,997
Tresiba Flextouch U-100Insulin Degludec65$53,862
FarxigaDapagliflozin Propanediol45$52,686
Humulin R U-500 KwikpenInsulin Regular, Human29$51,792
Tresiba Flextouch U-200Insulin Degludec28$39,989
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$34,511
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/725$19,026
Lantus SolostarInsulin Glargine,hum.Rec.Anlog129$18,759
Humalog Kwikpen U-100Insulin Lispro57$18,376
Novolog FlexpenInsulin Aspart36$10,554
JanuviaSitagliptin Phosphate19$9,207
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$8,667

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Insulin Lispro$29$475,745316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 383 gerontology providers in Pennsylvania.

Other gerontology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →